Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Nicholas J Goulden"'
Autor:
Ashish Narayan Masurekar, Catriona A Parker, Milensu Shanyinde, Anthony V Moorman, Jeremy P Hancock, Rosemary Sutton, Philip J Ancliff, Mary Morgan, Nicholas J Goulden, Chris Fraser, Peter M Hoogerbrugge, Tamas Revesz, Philip J Darbyshire, Shekhar Krishnan, Sharon B Love, Vaskar Saha
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e108107 (2014)
The outcomes of Central Nervous System (CNS) relapses in children with acute lymphoblastic leukaemia (ALL) treated in the ALL R3 trial, between January 2003 and March 2011 were analysed. Patients were risk stratified, to receive a matched donor allog
Externí odkaz:
https://doaj.org/article/a33a747b941a4d608fce934190131089
Autor:
Jasmeet Sidhu, Ashish Narayan Masurekar, Manash Pratim Gogoi, Caroline Fong, Tasos Ioannou, Taha Lodhi, Catriona Parker, Jizhong Liu, Amy A. Kirkwood, Anthony V. Moorman, Kiranmoy Das, Nicholas J. Goulden, Ajay Vora, Vaskar Saha, Shekhar Krishnan
Publikováno v:
British Journal of Haematology. 198:142-150
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dab2acb7c4794bb5f513bda566b1870f
https://doi.org/10.1111/bjh.18158
https://doi.org/10.1111/bjh.18158
Autor:
Jasmeet, Sidhu, Ashish Narayan, Masurekar, Manash Pratim, Gogoi, Caroline, Fong, Tasos, Ioannou, Taha, Lodhi, Catriona, Parker, Jizhong, Liu, Amy A, Kirkwood, Anthony V, Moorman, Kiranmoy, Das, Nicholas J, Goulden, Ajay, Vora, Vaskar, Saha, Shekhar, Krishnan
Publikováno v:
British journal of haematology. 198(1)
In successive UK clinical trials (UKALL 2003, UKALL 2011) for paediatric acute lymphoblastic leukaemia (ALL), polyethylene glycol-conjugated E. coli L-asparaginase (PEG-EcASNase) 1000 iu/m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::74215ea2f59f0ffd06d5f726ca57e2f7
https://pubmed.ncbi.nlm.nih.gov/35348200
https://pubmed.ncbi.nlm.nih.gov/35348200
Autor:
Christopher J.C. Knechtli, Nicholas J. Goulden, Jeremy P. Hancock, Victoria L.G. Grandage, Emma L. Harris, Russell J. Garland, Claire G. Jones, Anthony W. Rowbottom, Linda P. Hunt, Ann F. Green, Emer Clarke, Alan W. Lankester, Jacqueline M. Cornish, Derwood H. Pamphilon, Colin G. Steward, Anthony Oakhill
Publikováno v:
Blood. 92:4072-4079
The efficacy of allografting in acute lymphoblastic leukemia (ALL) is heavily influenced by remission status at the time of transplant. Using polymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis, we have investigated retrospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af6766713b8719d578c7a2a07fb62583
https://doi.org/10.1182/blood.v92.11.4072.423k33_4072_4079
https://doi.org/10.1182/blood.v92.11.4072.423k33_4072_4079
Autor:
J Hancock, John Moppett, V H J van der Velden, A. J. M. Wijkhuijs, Nicholas J. Goulden, J J M van Dongen
Publikováno v:
Leukemia. 17:268-270
Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: reversal by addition of bovine serum albumin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a3fa6c7f8d31830c5c6180309dcc33c
https://doi.org/10.1038/sj.leu.2402751
https://doi.org/10.1038/sj.leu.2402751
Publikováno v:
Paediatric drugs. 5(12)
Thromboembolic disease (TED) is increasingly recognized as a major cause of morbidity and mortality in tertiary pediatrics. Children younger than 1 year of age and teenage girls are at greatest risk of thromboembolism. Although anticoagulation therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b44f11ef79aa0a5ebf2d1bc3426f355
https://pubmed.ncbi.nlm.nih.gov/14658922
https://pubmed.ncbi.nlm.nih.gov/14658922
Autor:
Nicholas J. Goulden, David Carrington, David I. Marks, Colin G. Steward, J Cornish, A.B.M. Foot, A Oakhill, Derwood Pamphilon, Milind D. Ronghe
Publikováno v:
British journal of haematology. 118(4)
Summary. The impact of transfusion of leucodepleted platelet concentrates (PCs) on cytomegalovirus (CMV) disease was assessed in 215 allogeneic (145 unrelated and 70 related donor) transplants over 3 years. In 43%, both donor and patient were CMV ser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73314e580272f62fbc9347c9500f7259
https://pubmed.ncbi.nlm.nih.gov/12199795
https://pubmed.ncbi.nlm.nih.gov/12199795
Publikováno v:
Blood. 104:5169-5169
BMT remains the treatment of choice for early BM relapse of childhood ALL. We reasoned that further intensification of cytoreductive therapy pre-BMT may further improve survival amongst those with the highest risk of treatment failure, early BM relap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96ffb8ac766c3454fb6ede89502a70b3
https://doi.org/10.1182/blood.v104.11.5169.5169
https://doi.org/10.1182/blood.v104.11.5169.5169